Indian mutual funds raised buying of Reliance, Swiggy and Gland Pharma in September
Value Research analysis of Indian fund portfolios for August and September 2026 shows the biggest purchases among large, mid and small caps.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to Moody's, citing an analysis by Value Research, Indian mutual funds bought the most Reliance Industries shares among large caps in September 2026, worth Rs 4,605 crore, with total holdings of Rs 99,267 crore. NSE, HDFC Bank, ICICI Bank and Bajaj Finance followed. In mid caps, Swiggy led with purchases of Rs 3,241 crore, while Gland Pharma topped small caps with Rs 1,849 crore.
The analysis highlights banking, financial services, pharmaceuticals and technology companies. It covers actively managed funds excluding passive schemes, based on August and September disclosures, with purchase values calculated at month-end prices.
why it matters
For the market, the gap between a month's purchase volume and total holdings matters, since heavy buying does not guarantee future returns. Analysts note that fund decisions depend on valuations, earnings expectations and each scheme's objectives, so such lists are best read as background information rather than a signal to act.
tags
instruments
sources
- Where are mutual funds investing your money? These stocks saw the biggest buying in September 2026. Check full list — Moody's, 27 October 2026 at 18:20 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗